Integra LifeSciences Launches Integra Titan Reverse Shoulder System-S

Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, announced the full market release of the Integra Titan Reverse Shoulder System-S (RSS-S).  This launch includes a new glenoid baseplate design to expand the Integra Titan Reverse Shoulder System.

As quoted in the press release:

The new glenoid baseplate was designed with advanced imaging analysis to improve fit and stability for patients of varying anatomy. In reverse shoulder arthroplasty, strong fixation in the patient’s bone is key for long-term success of the implant construct.  The new RSS-S baseplate was designed to achieve immediate fixation with an independent central screw, and the porous-coated central post allows the patient’s bone to grow onto the implant to further maximize the potential for long-term fixation.

“We designed the Titan Reverse Shoulder System-S to leverage the latest data on glenoid morphology in various patient populations, while streamlining the instrumentation to improve the flow of each case,” said Dr. Matthew Ramsey of the Rothman Institute and a design surgeon of the system. “The new system builds upon the established legacy of our diaphyseal-fit humeral stems, which allow me to treat my patients without cement in primary and revision surgeries.”

Click here to read the full press release.